ARWR - Arrowhead PharmaceuticalsEPS of -$0.39 revenue of $62.55M February, 06 2023 04:03 PM Arrowhead Pharmaceuticals Inc. Arrowhead Pharmaceuticals press release ( NASDAQ: ARWR ): Q1 EPS of -$0.39 may not be comparable to consensus of $0.13. Revenue of $62.55M (+128.3% Y/Y). For further details see: Arrowhead PharmaceuticalsEPS of -$0.39, revenue of $62.55M